Use of Retroviral Markers to Identify Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Transplantation in Indolent B Cell Neoplasms (Follicular Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (CLL) Patients)

Albert Deisseroth, Hagop Kantarjian, Richard Champlin, Fernando Cabanillas, Michael Keating, Chris Reading, Borje Andersson, David Claxton, Bud Robertson, Susan Escudier, Michael Andreeff, Susan O’brien, Steven Kornblau, Debra Ellerson, Elie Hanania, Siqing Fu

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Use of Retroviral Markers to Identify Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Transplantation in Indolent B Cell Neoplasms (Follicular Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (CLL) Patients)'. Together they form a unique fingerprint.